4.7 Article

Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape

Journal

CELL HOST & MICROBE
Volume 22, Issue 3, Pages 343-+

Publisher

CELL PRESS
DOI: 10.1016/j.chom.2017.07.016

Keywords

-

Funding

  1. Arnold O. Beckman Postdoctoral Fellowship
  2. Tri-Institutional Training Program in Computational Biology and Medicine (via NIH) [T32GM083937]
  3. PhRMA Foundation Pre-Doctoral Informatics Fellowship
  4. NIH [R01CA194547, U24CA210989]
  5. Rita Allen Scholars Program
  6. Irma T. Hirschl Award
  7. Sinsheimer Foundation Award
  8. Burroughs Wellcome Fund PATH award
  9. NIH Director's New Innovator Award [1DP2AI104556-01]
  10. HHMI-Simons Faculty Scholar Award

Ask authors/readers for more resources

CRISPR loci are a cluster of repeats separated by short spacer sequences derived from prokaryotic viruses and plasmids that determine the targets of the host's CRISPR-Cas immune response against its invaders. For type I and II CRISPR-Cas systems, single-nucleotide mutations in the seed or proto-spacer adjacent motif (PAM) of the target sequence cause immune failure and allow viral escape. This is overcome by the acquisition of multiple spacers that target the same invader. Here we show that targeting by the Staphylococcus epidermidis type III-A CRISPR-Cas system does not require PAM or seed sequences, and thus prevents viral escape via single-nucleotide substitutions. Instead, viral escapers can only arise through complete target deletion. Our work shows that, as opposed to type I and II systems, the relaxed specificity of type III CRISPR-Cas targeting provides robust immune responses that can lead to viral extinction with a single spacer targeting an essential phage sequence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available